G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.4 SEK 32% Market Closed
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
EPS (Diluted) Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
EPS (Diluted)
kr0
CAGR 3-Years
13%
CAGR 5-Years
27%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
EPS (Diluted)
kr1
CAGR 3-Years
-30%
CAGR 5-Years
4%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
EPS (Diluted)
-kr28
CAGR 3-Years
-195%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
EPS (Diluted)
kr3
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
15%
MedCap AB (publ)
STO:MCAP
EPS (Diluted)
kr14
CAGR 3-Years
51%
CAGR 5-Years
53%
CAGR 10-Years
25%
M
Magle Chemoswed Holding AB
STO:MAGLE
EPS (Diluted)
kr1
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genovis AB's EPS (Diluted)?
EPS (Diluted)
0.3 SEK

Based on the financial report for Jun 30, 2024, Genovis AB's EPS (Diluted) amounts to 0.3 SEK.

What is Genovis AB's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
27%

Over the last year, the EPS (Diluted) growth was -70%. The average annual EPS (Diluted) growth rates for Genovis AB have been 13% over the past three years , 27% over the past five years .

Back to Top